Pharma & Biotech

Add to MyProactive

XPhyto Therapeutics Corp. -

XPhyto Therapeutics eyeing Europe sales launch of its coronavirus RT-PCR test in April this year

1 week, 3 days ago

Psyched Wellness -

Psyched Wellness is pioneering research into the health benefits of Amanita Muscaria mushrooms

1 week, 3 days ago

Pharmaxis Ltd - Pharmaxis enrols first patient in clinical trial for PXS‐5505, a potential new treatment for bone marrow cancer myelofibrosis

Pharmaxis enrols first patient in clinical trial for PXS‐5505, a potential new treatment for bone marrow cancer myelofibrosis

1 week, 4 days ago

Magic mushrooms

Numinus Wellness looking to position itself at the forefront of psychedelics for healing and wellness

1 week, 6 days ago

Algernon Pharmaceuticals Inc. -

Algernon Pharmaceuticals selects Dalton Pharma Services to synthesize DMT for its stroke studies

1 week, 6 days ago

Universal Ibogaine holds Masterclass to spread the message of Ibogaine

Universal Ibogaine holds Masterclass to spread the message of Ibogaine

2 weeks ago

Lobe Sciences Ltd -

Lobe Sciences: Find out more about the company advancing transformational treatments for brain injuries

2 weeks ago

Silo Pharma Inc -

Silo Pharma: Meet the team bridging the gap between traditional pharmaceuticals and psychedelic therapies

2 weeks ago

ANGLE PLC -

Proactive news headlines: MGC Pharmaceuticals, ANGLE, Scirocco Energy, Inspiration Healthcare...

2 weeks ago

MindMed -

MindMed to acquire AI medicine company HealthMode in cash and stock deal

2 weeks ago

Numinus Wellness Inc. -

Numinus Wellness's trial for MDMA-assisted therapy is in pre-implementation stage

2 weeks ago

Cannabis leaf next to bottle, dropper and possibly a joint

Heritage Cannabis is pioneering the seed-to-sale cannabis model

2 weeks ago

ANGLE PLC - ANGLE says Parsortix system able to harvest difficult-to-detect mesenchymal cancer cells

ANGLE says Parsortix system able to harvest difficult-to-detect cancer cells

2 weeks ago

RedHill Biopharma -

RedHill Biopharma (NASDAQ:RDHL) announces first patient dosed in U.S. Phase 2/3 COVID-19 outpatient study of RHB-107

2 weeks, 1 day ago

Montreal Heart Institute starting a clinical trial with Hesperco for treatment of COVID-19

Montreal Heart Institute starting a clinical trial with Hesperco for treatment of COVID-19

2 weeks, 1 day ago

Wesana Health - Wesana Health CEO and former NHL player studying psilocybin to cure traumatic brain injuries

Wesana Health CEO and former NHL player studying psilocybin to cure traumatic brain injuries

2 weeks, 1 day ago

RedHill Biopharma -

RedHill Biopharma says first patient dosed in ground-breaking RHB-107 Phase 2/3 study of coronavirus outpatients

2 weeks, 1 day ago

Valeo Pharma Inc. - Valeo Pharma Inc says its Hesperco capsules will be at the core of the Montreal Heart Institute's clinical trial to evaluate the effect of hesperidin on coronavirus (COVID-19) symptoms

Valeo Pharma says its Hesperco capsules at core of Montreal Heart Institute's clinical trial to evaluate hesperidin on coronavirus symptoms

2 weeks, 1 day ago

Blue brain graphic with pinkish dots

Kintara Therapeutics enrolls last patient in Phase 2 VAL-083 trial for recurrent glioblastoma multiforme

2 weeks, 1 day ago

Magic mushrooms

Revive Therapeutics signs asset purchase agreement with Newscope Capital to acquire the full rights to PharmaTher's IP relating to psilocybin

2 weeks, 1 day ago